TopoTarget granted Multimeric exclusive rights to TopoTarget's multimeric fusion proteins for all therapeutic uses

Topotarget A/S

Denmark / Small-Cap Biopharma (<$1 billion)

$46.3m on 11/04/2011 [market cap]

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Multimeric Biotherapeutics Inc.

U.S. / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced